Brian Taylor Slingsby - 19 Feb 2026 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Feb 2026, 19:47:18 UTC
Prior SEC filing
21 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Catalys Pacific Fund, LP, By: Catalys Pacific Fund GP, LP, its General Partner, By: Catalys Pacific, LLC, its General Partner, By: Brian Taylor Slingsby, its Managing Partner, By: /s/ Adam Levy, Attorney-in-fact

Key filing fact

Brian Taylor Slingsby filed Form 4 for Mineralys Therapeutics, Inc. (MLYS) on 20 Feb 2026.

Key facts

  • This page summarizes Brian Taylor Slingsby's Form 4 filing for Mineralys Therapeutics, Inc. (MLYS).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 20 Feb 2026, 19:47.

Change

  • Previous filing in this sequence was filed on 21 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001963901 Primary reporting owner

Slingsby Brian Taylor

Relationship
Director, 10%+ Owner
Address
1700 WESTLAKE AVE. N, SUITE 200, THINKSPACE, SEATTLE
Signature
Catalys Pacific Fund, LP, By: Catalys Pacific Fund GP, LP, its General Partner, By: Catalys Pacific, LLC, its General Partner, By: Brian Taylor Slingsby, its Managing Partner, By: /s/ Adam Levy, Attorney-in-fact
Signature date
20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MLYS transaction

Common Stock

Award

Transaction value
$0
Shares
+6,200
Change %
Price
$0.000000
Shares after
6,200
Date
19 Feb 2026
Ownership
Direct
Footnotes
F1
MLYS transaction

Common Stock

Other

Transaction value
$0
Shares
-6,200
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Footnotes
F1, F2
MLYS transaction

Common Stock

Other

Transaction value
$0
Shares
+6,200
Change %
+0.08%
Price
$0.000000
Shares after
7,910,038
Date
19 Feb 2026
Ownership
See footnote
Footnotes
F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MLYS transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+8,300
Change %
Price
$0.000000
Shares after
8,300
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,300
Exercise price
$28.06
Footnotes
F4
MLYS transaction Derivative

Stock Option

Other

Transaction value
$0
Shares
-8,300
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,300
Exercise price
$28.06
Footnotes
F2, F4
MLYS transaction Derivative

Stock Option

Other

Transaction value
$0
Shares
+8,300
Change %
Price
$0.000000
Shares after
8,300
Date
19 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
8,300
Exercise price
$28.06
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant.

Footnote F2

Represents stock options or RSUs transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP.

Footnote F3

Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Footnote F4

The stock option vests in 12 substantially equal monthly installments following the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .